ANTIENDOTOXIN MONOCLONAL-ANTIBODIES FOR GRAM-NEGATIVE SEPSIS - GUIDELINES FROM THE IDSA

被引：26
|
作者：
WENZEL, RP
ANDRIOLE, VT
BARTLETT, JG
BATT, MD
BULLOCK, WE
COBBS, CG
LIGHT, B
MARTIN, MA
SANFORD, J
SANDE, MA
机构：
[1] YALE UNIV,SCH MED,DEPT MED,333 CEDAR ST,201 LCI,NEW HAVEN,CT 06510
[2] VET AFFAIRS MED CTR,BIRMINGHAM,AL
[3] OREGON HLTH SCI UNIV,PORTLAND,OR 97201
[4] UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20814
[5] LUTHERAN GEN HOSP,DIV HOSP EPIDEMIOL,PK RIDGE,IL 60068
[6] JOHNS HOPKINS UNIV HOSP,DIV INFECT DIS,BALTIMORE,MD 21205
[7] UNIV CINCINNATI,MED CTR,DIV INFECT DIS,CINCINNATI,OH 45267
[8] SAN FRANCISCO GEN HOSP,SAN FRANCISCO,CA 94110
[9] UNIV IOWA,COLL MED,DEPT INTERNAL MED,DIV GEN MED CLIN EPIDEMIOL & HLTH SERV RES,IOWA CITY,IA 52242
[10] ST BONIFACE GEN HOSP,WINNIPEG R2H 2A6,MANITOBA,CANADA
来源：
CLINICAL INFECTIOUS DISEASES | 1992年 / 14卷 / 04期
关键词：
D O I：
10.1093/clinids/14.4.973
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：973 / 976
页数：4
相关论文
共 50 条
  • [31] FURTHER CHARACTERIZATION OF MURINE MONOCLONAL-ANTIBODIES REACTIVE WITH GRAM-NEGATIVE LIPOPOLYSACCHARIDE CORE REGION
    APPELMELK, BJ
    VUGHT, AMJJV
    MAASKANT, JJ
    MACLAREN, DM
    THIJS, LG
    JOURNAL OF MEDICAL MICROBIOLOGY, 1986, 21 (04) : R8 - R8
  • [32] PLANNING FOR FINANCIAL IMPACT OF ANTIENDOTOXIN MONOCLONAL-ANTIBODIES
    BAILEY, G
    DENMAN, JW
    KILLILEA, T
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (07): : 1672 - 1673
  • [33] ANTIENDOTOXIN MONOCLONAL-ANTIBODIES - WHAT FUTURE NOW
    SUSLA, GM
    DEW, RB
    DRUG SAFETY, 1994, 11 (04) : 215 - 222
  • [34] CONTROVERSIES REGARDING THE USE OF ANTIENDOTOXIN MONOCLONAL-ANTIBODIES
    DUNN, DL
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1993, 2 (06) : 456 - 462
  • [35] Lipopolyamines: Novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria
    David, SA
    Silverstein, R
    Amura, CR
    Kielian, T
    Morrison, DC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 912 - 919
  • [36] DEVELOPMENT OF MONOCLONAL-ANTIBODIES AGAINST VIRULENT GRAM-NEGATIVE BACTERIA - EFFICACY IN A SEPTIC MOUSE MODEL
    ANTONACCI, AC
    CHIAO, J
    CALVANO, SE
    SENTERFIT, L
    SHIRES, GT
    DINEEN, P
    SURGICAL FORUM, 1984, 35 : 116 - 119
  • [37] FUNCTIONAL-ACTIVITY OF MONOCLONAL-ANTIBODIES AGAINST LIPOPOLYSACCHARIDE (LPS) ANTIGENS OF GRAM-NEGATIVE BACILLI
    YOUNG, LS
    CLINICAL RESEARCH, 1984, 32 (02): : A518 - A518
  • [38] PRODUCTION AND CHARACTERIZATION OF MOUSE MONOCLONAL-ANTIBODIES REACTING WITH THE LIPOPOLYSACCHARIDE CORE REGION OF GRAM-NEGATIVE BACILLI
    APPELMELK, BJ
    VERWEIJVANVUGHT, AMJJ
    MAASKANT, JJ
    SCHOUTEN, WF
    DEJONGE, AJR
    THIJS, LG
    MACLAREN, DM
    JOURNAL OF MEDICAL MICROBIOLOGY, 1988, 26 (02) : 107 - 114
  • [39] OPSONIC ACTIVITY OF POLYCLONAL AND MONOCLONAL-ANTIBODIES RAISED AGAINST GRAM-NEGATIVE COMMON CORE GLYCOLIPID
    MEHTA, ND
    RAPSON, N
    WILSON, BM
    EASMON, CSF
    JOURNAL OF MEDICAL MICROBIOLOGY, 1986, 21 (04) : R8 - R8
  • [40] Gram-positive sepsis - Mechanisms and differences from gram-negative sepsis
    Sriskandan, S
    Cohen, J
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1999, 13 (02) : 397 - +
12345